Clinical Rheumatology

, Volume 26, Issue 8, pp 1344–1345

Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept

  • V. Bagalas
  • I. Kioumis
  • P. Argyropoulou
  • D. Patakas
Case Report

DOI: 10.1007/s10067-006-0356-5

Cite this article as:
Bagalas, V., Kioumis, I., Argyropoulou, P. et al. Clin Rheumatol (2007) 26: 1344. doi:10.1007/s10067-006-0356-5

Abstract

Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised patients. Antitumor necrosis factor-α (TNF-α) treatment of rheumatoid arthritis can result in clinical benefits, but with an increased risk of opportunistic infections. Leishmania infection in patients treated with TNF-α antagonists is extremely rare; for this reason, we report a patient with VL after etanercept treatment who had an unfavorable outcome.

Keywords

EtanerceptRheumatoid arthritisTNF-α antagonistsVisceral leishmaniasis

Copyright information

© Clinical Rheumatology 2006

Authors and Affiliations

  • V. Bagalas
    • 1
  • I. Kioumis
    • 1
  • P. Argyropoulou
    • 1
  • D. Patakas
    • 1
  1. 1.Department of Pulmonary DiseaseAristotle University of Thessaloniki Medical School–“G. Papanikolaou” HospitalExohiGreece